CompletedPhase 3NCT00748644
Efficacy Study of Two Treatments in the Remission of Vasculitis
Studying Granulomatosis with polyangiitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Loic Guillevin, MD, PhD, NPCFrench Vasculitis Study Group
- Intervention
- Rituximab(drug)
- Enrollment
- 117 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2008 – 2013
Study locations (1)
- Hopital Cochin, Paris, France
Collaborators
URC-CIC Paris Descartes Necker Cochin
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00748644 on ClinicalTrials.govOther trials for Granulomatosis with polyangiitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06940661Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With PolyangiitisAssistance Publique - Hôpitaux de Paris
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT03919435TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With PolyangiitisUniversity of Pennsylvania
- ACTIVE NOT RECRUITINGPHASE3NCT01933724The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric ApproachUniversity of South Florida